β-Glycerophosphate disodium salt pentahydrate
Synonym(s):β-glycerolphosphate;β-GP;Disodium β-glycerol phosphate pentahydrate;glycerol-2-phosphate
- CAS NO.:13408-09-8
- Empirical Formula: C3H12NaO7P
- Molecular Weight: 214.09
- MDL number: MFCD00149084
- EINECS: 639-414-7
- SAFETY DATA SHEET (SDS)
- Update Date: 2024-11-20 11:41:24
What is β-Glycerophosphate disodium salt pentahydrate?
Description
β-
Chemical properties
Solid
The Uses of β-Glycerophosphate disodium salt pentahydrate
β-Glycerol Phosphate was shown to have promoted mineralization in vitro by modulating bone cell metabolic activity and/or serving as a local source of inorganic phosphate ions.
The Uses of β-Glycerophosphate disodium salt pentahydrate
Sodium β-glycerophosphate pentahydrate is used as a phosphatase inhibitor. It promotes bone matrix mineralization while delivering to osteoblasts by providing a source of phosphate ions. It is used in the development of hydrogels and scaffolds, which finds applications in tissue engineering and cell growth. It is used as an additive in isolation mediums by providing phosphate ions to isolate. It is utilized to promote mineralization in vitro by modulating bone cell metabolic activity.
What are the applications of Application
β-Glycerophosphate disodium salt pentahydrate is a potent phosphatase inhibitor
General Description
A phosphate group donor in matrix mineralization studies. Accelerates calcification in vascular smooth muscle cells. Also acts as a protein phosphatase inhibitor.
Biochem/physiol Actions
Beta-Glycerophosphate is a classical serine-threonine phosphatase inhibitor used in kinase reaction buffers. BGP is often used in combination with other phosphatase/protease inhibitors for broad spectrum inhibition. It functions as an organic phosphate donor and has been used in culture media for mesenchymal stem cell differentiation to osteoblast-type cells. BGP is also used to buffer M17 media for Lactococcus culture in recombinant protein expression
Purification Methods
Crystallise it from water. [Attwood et al. Biochem J 253 389 1988, Beilstein 1 IV 2766.]
References
[1]. chung ch, golub ee, forbes e, et al. mechanism of action of beta-glycerophosphate on bone cell mineralization. calcif tissue int. 1992 oct;51(4):305-11.
[2]. fujimoto h, mabuchi i. isolation of cleavage furrows from eggs of regular sea urchins and identification of furrow-specific proteins. j biochem. 1997 sep;122(3):518-24.
[3]. lecanda f, avioli lv, cheng sl. regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2. j cell biochem. 1997 dec 1;67(3):386-96.
[4]. shioi a, nishizawa y, jono s, et al. beta-glycerophosphate accelerates calcification in cultured bovine vascular smooth muscle cells. arterioscler thromb vasc biol. 1995 nov;15(11):2003-9.
Properties of β-Glycerophosphate disodium salt pentahydrate
Melting point: | >300°C |
storage temp. | 2-8°C |
solubility | H2O: 0.1 g/mL, clear, colorless |
form | White powder |
color | Whiteto Off-White |
Water Solubility | Soluble in water. |
Merck | 14,8622 |
BRN | 3744328 |
Stability: | Hygroscopic |
InChI | InChI=1S/C3H9O6P.Na.H2O.H/c4-1-3(2-5)9-10(6,7)8;;;/h3-5H,1-2H2,(H2,6,7,8);;1H2; |
Safety information for β-Glycerophosphate disodium salt pentahydrate
Signal word | Warning |
Pictogram(s) |
Exclamation Mark Irritant GHS07 |
GHS Hazard Statements |
H302:Acute toxicity,oral H315:Skin corrosion/irritation H319:Serious eye damage/eye irritation H332:Acute toxicity,inhalation H335:Specific target organ toxicity, single exposure;Respiratory tract irritation |
Precautionary Statement Codes |
P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P280:Wear protective gloves/protective clothing/eye protection/face protection. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. |
Computed Descriptors for β-Glycerophosphate disodium salt pentahydrate
InChIKey | PEMUISUYOHQFQH-UHFFFAOYSA-L |
SMILES | O(P(O)(O)=O)C(CO)CO.[NaH].O |
Abamectin manufacturer
ALS INDIA LIFE SCIENCES
New Products
4-Aminotetrahydropyran-4-carbonitrile Hydrochloride (R)-3-Aminobutanenitrile Hydrochloride 4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HCL 4-(Dimethylamino)tetrahydro-2H-pyran-4-carbonitrile 3-((Dimethylamino)methyl)-5-methylhexan-2-one oxalate 1,4-Dioxa-8-azaspiro[4.5]decane 5-Bromo-2-nitropyridine Nimesulide BP Aceclofenac IP/BP/EP Diclofenac Sodium IP/BP/EP/USP Mefenamic Acid IP/BP/EP/USP Ornidazole IP Diclofenac Potassium SODIUM AAS SOLUTION ZINC AAS SOLUTION BUFFER SOLUTION PH 10.0(BORATE) GOOCH CRUCIBLE SINTERED AQUANIL 5 BERYLLIUM AAS SOLUTION 2-Bromo-1-(bromomethyl)-3-chloro-5-nitrobenzene 2-Bromo-3-nitroaniline N-(3-Hydroxypropyl)-N-methylacetamide 3-Bromo-6-chloropyridazine 4-ethyl-3-nitrobenzoic acidRelated products of tetrahydrofuran
You may like
-
13408-09-8 Disodium beta-glycerol phosphate pentahydrate 98%View Details
13408-09-8 -
Sodium Beta-Glycerophosphate Pentahydrate CAS 13408-09-8View Details
13408-09-8 -
Sodium beta-glycerophosphate pentahydrate CAS 13408-09-8View Details
13408-09-8 -
Sodium-ß-glycerophosphate, GR 99%+ CAS 13408-09-8View Details
13408-09-8 -
Disodium β-Glycerophosphate Pentahydrate CAS 13408-09-8View Details
13408-09-8 -
Disodium β-Glycerophosphate Pentahydrate [for Biochemical Research] CAS 13408-09-8View Details
13408-09-8 -
SODIUM-β-GLYCEROPHOSPHATE PENTAHYDRATE AR CAS 13408-09-8View Details
13408-09-8 -
β-Glycerol phosphate disodium salt pentahydrate CAS 13408-09-8View Details
13408-09-8